Загрузка...
Efficacy of bortezomib in sarcomas with high levels of MAP17 (PDZK1IP1)
Sarcomas are malignant tumors accounting for a high percentage of cancer morbidity and mortality in children and young adults. Surgery and radiation therapy are the accepted treatments for most sarcomas; however, patients with metastatic disease are treated with systemic chemotherapy. Many tumors di...
Сохранить в:
| Опубликовано в: : | Oncotarget |
|---|---|
| Главные авторы: | , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Impact Journals LLC
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5341855/ https://ncbi.nlm.nih.gov/pubmed/27563810 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.11475 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|